Jump to content

Narcobarbital

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by DePiep (talk | contribs) at 18:18, 2 April 2016 (Remove redundant parameters InChI, InChIKey (StdInChI, StdInChIKey are used). See Talk (via AWB script)). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Narcobarbital
Clinical data
ATC code
Identifiers
  • 5-(2-bromoprop-2-en-1-yl)-5-isopropyl-1-methylpyrimidine-2,4,6(1H,3H,5H)-trione
CAS Number
PubChem CID
ChemSpider
KEGG
ChEMBL
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC11H15BrN2O3
Molar mass303.152 g/mol g·mol−1
3D model (JSmol)
  • O=C1N(C(=O)NC(=O)C1(CC(\Br)=C)C(C)C)C
  • InChI=1S/C11H15BrN2O3/c1-6(2)11(5-7(3)12)8(15)13-10(17)14(4)9(11)16/h6H,3,5H2,1-2,4H3,(H,13,15,17) checkY
  • Key:WGMASVSHOSNKMF-UHFFFAOYSA-N checkY
  (verify)

Narcobarbital (Pronarcon) is a barbiturate derivative developed by Riedel de Hean in the 1930s.[1] It is an N-methylated derivative of propallylonal and has similar sedative effects. It is still used in veterinary medicine for inducing surgical anaesthesia.

References

  1. ^ US Patent 2080071



Stub icon

This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it.

Retrieved from "https://en.wikipedia.org/w/index.php?title=Narcobarbital&oldid=713219547"